NCT00036244已完成3 期
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 26
研究概览
简要总结
The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 32 Months 至 59 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (26)
Loading locations...
相似试验
已完成
2 期
Safety Study of Anti-IgE Immunotherapy in Allergic PatientsAllergyNCT00439621Resistentia Pharmaceuticals AB42
已完成
1 期
A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHTGlaucoma and Ocular HypertensionNCT01654484Santen Inc.60
撤回
1 期
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic DermatitisAtopic DermatitisNCT06055374Brexogen Inc.
已完成
2 期
Intravenous Tapentadol in Post-Bunionectomy PainBunionPainNCT01435577Grünenthal GmbH177
已完成
不适用
SUPARTZ Versus Placebo in Osteoarthritis of the ShoulderOsteoarthritis of the ShoulderNCT00479687Bioventus LLC300